Compare INUV & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | PLUR |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 25.5M |
| IPO Year | 1996 | 2001 |
| Metric | INUV | PLUR |
|---|---|---|
| Price | $1.18 | $1.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $11.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 148.0K | 31.1K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | 10.78 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $86,209,305.00 | $1,336,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | $12.89 | $293.97 |
| P/E Ratio | $8.38 | ★ N/A |
| Revenue Growth | 2.88 | ★ 309.82 |
| 52 Week Low | $1.00 | $1.78 |
| 52 Week High | $6.27 | $5.68 |
| Indicator | INUV | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 27.38 |
| Support Level | $1.00 | N/A |
| Resistance Level | $2.01 | $2.53 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 47.44 | 15.00 |
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.